🔎 Trials Near Me

Home › NCT07743645

Developing Biomarker-Supported Schizophrenia Spectrum Disorder (SSD) Prevention

RecruitingHealthy volunteers welcome

Developing Biomarker-Supported SSD Prevention

Who can join

Ages 9 to 19 · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Family history of SSD (defined as first-degree (e.g., a parent or a sibling), second-degree (e.g., an uncle or a grandparent), or other combinations of biological relatives in the family have or likely have a diagnosis of SSD or other closely related severe mental illnesses equivalent to at least 25% of genetic sharing) per medical record review and/or parent/legal guardian report and confirmed by a structured interview
* screening positive for two or more risk factors targeted by the intervention
* Participants and parent(s)/legal guardian(s) agree to participate
* psychiatrically stable and have no major changes in antidepressant, stimulant, or antipsychotic medication in the past 4 weeks.

Exclusion Criteria:

* Current or past history of psychotic disorders or clinical high risk for psychosis (CHR-p) per study interview
* Current or past antipsychotic medication use to specifically treat a psychotic disorder
* major medical and neurological conditions
* moderate to severe intellectual disabilities or mild intellectual disabilities but expected to have difficulty completing the study assessments;
* current drug or alcohol use that impacts functioning and study engagement;
* Not able to give assent, permission, or consent.
* Not able to undergo MRI.

About the study

The purpose of this study is to compare the effect of a brief family-based psychosocial intervention that addresses modifiable SSD risk factors on persistent and distressing psychotic-like experiences in children and young adults with a family history of SSD and high versus low baseline SSD-like brain patterns

What is being tested

Sponsor: The University of Texas Health Science Center, Houston · Participants: 100 · Started: Sep 1, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07743645

Locations in the U.S.

TexasThe University of Texas Health Science Center at Houston, Houston

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.